H-alpha-Me-L-Phe-OH

H-alpha-Me-L-Phe-OH is an L-phenylalanine derivative bearing an alpha-methyl substituent, giving a chiral amino acid framework with a stereogenic center at the alpha carbon and a free carboxylic acid suitable for peptide chemistry. The structure retains the benzyl side chain characteristic of phenylalanine, enabling hydrophobic and aromatic interactions in peptide and peptidomimetic contexts, while the alpha-methyl substitution can modulate conformational preferences and proteolytic stability. The molecule's primary amino functionality and acid group can be orthogonally managed through standard amino acid protection strategies to control chemoselective coupling and downstream transformations. As a chiral amino acid intermediate, H-alpha-Me-L-Phe-OH can be incorporated into peptide building blocks or converted into protected derivatives for stereodefined synthesis of modified amino acid sequences and SAR-focused analogs.

1. Peptide Synthesis

H-alpha-Me-L-Phe-OH supports peptide building block preparation for solid-phase peptide synthesis and solution-phase coupling by providing an L-configured amino acid core with a carboxylic acid handle and a side chain compatible with standard amide bond formation. The alpha-methyl substitution can be leveraged to introduce steric and conformational bias at the peptide backbone, which is relevant when constructing sequences that require altered secondary structure propensity or improved resistance to enzymatic cleavage. Protecting-group strategies can be applied by converting the amino acid to an N-protected form and, when needed, activating the acid for coupling to an appropriately protected amino component. Downstream, the resulting peptide analogs can be used to generate sequence libraries and backbone-modified constructs for peptide science workflows.

2. Peptidomimetics And SAR

H-alpha-Me-L-Phe-OH is suitable for peptidomimetic construction and structure-activity relationship studies because the alpha-methyl group and phenylalanine benzyl side chain together define both backbone sterics and aromatic functionality. The stereochemistry at the alpha carbon allows incorporation of a defined chiral center into analogs where conformational restriction and side-chain presentation are key determinants of molecular recognition. N-/C-terminal protection and selective deprotection enable systematic variation of coupling positions, facilitating the synthesis of analog series with controlled stereochemical identity. The resulting modified scaffolds can then be employed in SAR studies to correlate backbone substitution patterns with binding-site geometry and physicochemical properties.

3. Chiral Amino Acid Derivatization

H-alpha-Me-L-Phe-OH functions as a chiral amino acid intermediate for stereodefined derivatization, including conversion to amino acid esters, activated acids, and N-protected derivatives that support controlled downstream chemistry. The free carboxylic acid can be transformed into coupling-ready forms, while the amino group can be protected to enable selective functional group manipulation without racemization at the alpha stereocenter. The alpha-methyl substitution provides a handle for generating conformationally biased derivatives, including backbone-modified building blocks used in chiral synthesis programs. Downstream synthetic utility includes preparing intermediates for further side-chain or backbone functionalization while maintaining the L-configuration required for consistent stereochemical outcomes.

4. Chemical Biology Probes

H-alpha-Me-L-Phe-OH can be applied in chemical biology research as a backbone-modified amino acid for generating labeled or functionalized peptide probes that incorporate phenylalanine-like aromatic features. The alpha-methyl substitution may help tune peptide conformation and stability in biological assay conditions, which can be relevant when designing probes that must retain structural integrity during incubation. Protecting-group strategies allow orthogonal handling of the amino and carboxyl groups, enabling conjugation workflows such as attaching reporter handles through peptide coupling or post-coupling derivatization. The resulting modified biomolecular constructs can serve as reagents for studying molecular recognition, substrate specificity, and backbone-dependent behavior in biochemical assays.

5. Pharmaceutical Intermediate Preparation

H-alpha-Me-L-Phe-OH is suitable for pharmaceutical intermediate preparation within fine chemical and process chemistry pipelines that require chiral, stereodefined amino acid building blocks. The combination of an L-phenylalanine side chain and an alpha-methyl backbone substituent supports manufacturing of peptide-like intermediates used in the synthesis of modified drug candidates and development-stage analogs. Standard protection, activation, and coupling-compatible transformations can be designed around the amino and carboxyl functionalities to support reproducible intermediate formation and controlled stereochemical integrity. Downstream, protected amino acid derivatives and activated intermediates derived from H-alpha-Me-L-Phe-OH can be used to assemble larger scaffolds under industrially scalable synthetic planning.

6. Analytical Research Standards

H-alpha-Me-L-Phe-OH can be utilized as an analytical research standard and reference material for method development in amino acid profiling, chiral analysis, and peptide hydrolysate characterization. The defined alpha-methyl stereochemistry and phenylalanine aromatic side chain provide a distinct chromatographic and spectrometric signature compared with unsubstituted phenylalanine, supporting identification of backbone-modified residues. Preparation of protected derivatives or labeled analogs can be applied to improve detectability in targeted LC-MS or derivatization-based workflows. The compound's structural specificity makes it useful for verifying stereochemical identity and monitoring incorporation of alpha-methyl phenylalanine units in peptide synthesis and downstream quality control.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. The spatiotemporal control of signalling and trafficking of the GLP-1R

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry